Cigna Group Cash & Equivalents 2015-2025 | CI
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Cigna Group's current cash & equivalents?
Cigna Group (CI) annual cash & equivalents for 2024 was $7.55B, a 3.48% decline from 2023. Cigna Group cash & equivalents for the quarter ending September 30, 2025 was $6.03B.
What was Cigna Group's cash & equivalents in 2023?
Cigna Group annual cash & equivalents for 2023 was $7.82B, a 32.04% increase from 2022.
What was Cigna Group's cash & equivalents in 2022?
Cigna Group annual cash & equivalents for 2022 was $5.92B, a 16.59% increase from 2021.
What is Cigna Group's 5-year cash & equivalents CAGR?
Cigna Group cash & equivalents grew at a compound annual growth rate (CAGR) of 10.33% from FY2019 to FY2024, going from $4.62B to $7.55B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+10.3%
FY2019
$4.62B
→
FY2024
$7.55B
15161718192021222324
5 years selected
Company: Cigna GroupTicker: CISector: HealthcareIndustry: Hospital & Medical Service PlansView company profile →